| __timestamp | Amneal Pharmaceuticals, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 111110000 |
| Thursday, January 1, 2015 | 136870000 | 129714000 |
| Friday, January 1, 2016 | 204747000 | 139574000 |
| Sunday, January 1, 2017 | 191938000 | 218502000 |
| Monday, January 1, 2018 | 210451000 | 322876000 |
| Tuesday, January 1, 2019 | 202287000 | 427320000 |
| Wednesday, January 1, 2020 | 190585000 | 523667000 |
| Friday, January 1, 2021 | 209563000 | 491707000 |
| Saturday, January 1, 2022 | 200046000 | 515083000 |
| Sunday, January 1, 2023 | 167778000 | 241294000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and Galapagos NV have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Galapagos NV consistently outpaced Amneal, with its R&D expenses peaking at over 500% of Amneal's 2014 spending by 2020. This surge underscores Galapagos's commitment to pioneering new treatments. Meanwhile, Amneal's R&D budget showed a steady increase, peaking in 2018, before a slight decline in 2023. This trend reflects a more conservative approach, possibly focusing on optimizing existing products. As the pharmaceutical landscape continues to shift, these spending patterns offer a glimpse into each company's strategic priorities and their potential impact on future healthcare innovations.
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
AstraZeneca PLC vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Galapagos NV
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Amneal Pharmaceuticals, Inc. and MannKind Corporation
Amneal Pharmaceuticals, Inc. or Mesoblast Limited: Who Invests More in Innovation?
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV